Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
Clinical trial NCT00436007 · COMPLETED
Trial details
- NCT number
- NCT00436007
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-30
- Primary completion
- 2008-09-15
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.